Related Experiment Video

Updated: May 8, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.9K

A Training for Parents Prevents Clinically Relevant Handling Errors in the Use of Long-Term Antiseizure Medication

Almuth Kaune1,2,3, Pia Madeleine Schumacher1,2,4, Martina Patrizia Neininger1,2,5

  • 1ZAMS - Zentrum für Arzneimittelsicherheit, Universität Leipzig und Universitätsklinikum Leipzig Medizinische Fakultät, Leipzig, Germany.

Klinische Padiatrie
|December 27, 2024
PubMed

Insights

A new training program significantly reduced medication handling errors (ME) for parents administering long-term antiseizure medications (ASM) to children. This intervention improved drug safety for chronically ill pediatric patients by lowering high-risk errors.

Area of Science:

  • Pediatric Neurology
  • Patient Safety
  • Medication Management

Background:

  • Medication handling errors (ME) in long-term antiseizure medication (ASM) administration pose risks to patient safety.
  • Parental training programs to prevent these errors are limited.

Purpose of the Study:

  • To assess the effectiveness of a patient-specific, risk-adapted training intervention for parents administering ASM to children.
  • To compare medication handling errors in an intervention group receiving training versus a control group receiving routine care.

Main Methods:

  • A controlled prospective study involving parents of children (0-18 years) on long-term ASM.
  • Medication handling errors were assessed during home visits.
  • An expert panel classified the clinical risk of 54 ME types (Score-0 to Score-6).

Main Results:

  • The intervention group (IG) showed a reduction in ME per patient (median 5 to 4, p=0.018).
  • Total ME decreased from 589 in the control group (CG) to 432 in the IG.
  • Significant relative risk reductions (RRR) were observed for high-risk ME (Score-5: 55.0%, Score-4: 27.6%, Score-3: 23.1%) and administration steps (preparation: 56.6%, oral administration: 22.4%).

Conclusions:

  • The risk-adapted training significantly decreased high-risk medication handling errors compared to routine care.
  • The intervention enhanced drug safety for chronically ill children using long-term ASM.

More Related Videos

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

892
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.3K

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
230
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
179
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
118
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
254
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.6K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
23